|
|
|
Insider
Information: |
Kozarich John W |
Relationship: |
Director |
City: |
San Diego |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
3 |
|
Direct
Shares |
128,523 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$3,813,825 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
128,523 |
|
|
Total
Value |
$3,813,825 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
3
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
3
|
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
Percentage
Gain/Loss : |
0.0%
|
-27.5%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Ligand Pharmaceuticals Inc |
LGND |
Director |
2024-04-24 |
42,523 |
2006-01-04 |
0 |
Premium* |
|
Novelion Therapeutics Inc |
NVLN |
Director |
2015-06-29 |
57,000 |
2013-05-13 |
0 |
Premium* |
|
Travere Therapeutics, Inc |
TVTX |
Director |
2019-05-08 |
29,000 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 1 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-05-20 |
4 |
GD |
$0.00 |
$0 |
D/D |
350 |
43,361 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2021-05-11 |
4 |
D |
$128.56 |
$50,267 |
D/D |
(391) |
34,152 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2013-11-18 |
4 |
OE |
$14.86 |
$6,836 |
D/D |
460 |
41,726 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2018-06-19 |
4 |
A |
$0.00 |
$0 |
D/D |
493 |
31,142 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-05-15 |
4 |
GD |
$0.00 |
$0 |
D/D |
500 |
49,711 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
622 |
44,333 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2021-06-04 |
4 |
A |
$0.00 |
$0 |
D/D |
630 |
34,782 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2017-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
666 |
40,649 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
831 |
27,208 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
835 |
26,377 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-02-28 |
4 |
S |
$102.62 |
$93,179 |
D/D |
(908) |
41,209 |
0 |
% |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2015-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
925 |
50,211 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2007-08-29 |
4 |
B |
$6.14 |
$6,140 |
D/D |
1,000 |
15,378 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-02-17 |
4 |
B |
$9.90 |
$9,900 |
D/D |
1,000 |
13,726 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2011-11-11 |
4 |
B |
$11.79 |
$11,787 |
D/D |
1,000 |
27,098 |
2.39 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-05-02 |
4 |
AS |
$121.45 |
$121,568 |
D/D |
(1,000) |
43,711 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-06-01 |
4 |
AS |
$117.19 |
$117,419 |
D/D |
(1,000) |
42,983 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-07-01 |
4 |
AS |
$119.47 |
$121,402 |
D/D |
(1,000) |
41,983 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-08-01 |
4 |
AS |
$135.78 |
$137,569 |
D/D |
(1,000) |
40,983 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-09-07 |
4 |
AS |
$115.00 |
$115,000 |
D/D |
(1,000) |
39,983 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2022-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
1,004 |
42,213 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2023-06-09 |
4 |
A |
$0.00 |
$0 |
D/D |
1,142 |
39,630 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2013-11-25 |
4 |
OE |
$6.82 |
$8,833 |
D/D |
1,243 |
42,969 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-01-20 |
4 |
OE |
$59.40 |
$98,960 |
D/D |
1,666 |
51,377 |
0 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Director |
|
2016-01-20 |
4 |
AS |
$92.71 |
$158,173 |
D/D |
(1,666) |
49,711 |
0 |
- |
|
74 Records found
|
|
Page 1 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|